NVDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NVDA is a good long-term business, but it is not a clean buy right now for a beginner with $50,000-$100,000 who wants to invest long-term and is not waiting for a better entry. The stock is technically overbought, pre-market is weak, insider selling is heavy, and there is no AI Stock Picker or SwingMax buy signal today. My direct view: hold and wait rather than buy immediately.
NVDA is in a strong uptrend on the chart: SMA_5 > SMA_20 > SMA_200 and MACD histogram is positive and expanding, which confirms bullish momentum. However, RSI_6 at 88.129 signals the stock is very overbought. Price is hovering near resistance at R1 230.719, with the pre-market price at 230.6 and pre-market change -2.15%, suggesting near-term exhaustion after a strong run. The trend remains bullish, but short-term entry quality is poor.
Analyst sentiment is very positive, with multiple firms raising price targets and maintaining Buy/Outperform ratings. UBS, RBC, Cantor Fitzgerald, BofA, Susquehanna, Wells Fargo, New Street, Raymond James, and Argus all remain constructive on the AI growth story. Key bullish catalysts include strong Blackwell demand, expected GB300 ramp, upcoming Vera Rubin launch, and continued AI data center expansion. News flow also remains supportive for AI broadly, and Trump-Xi talks did not worsen chip export control tensions in the latest update.
Near-term negatives include the stock being overbought, pre-market weakness, and the broader market opening lower with S&P 500 down 0.95%. Insider trading is clearly negative, with insiders selling and selling increasing 1856.07% over the last month. Congress trading is also cautious, with 4 sales versus 3 purchases over the last 90 days. A bearish research note from Culper highlights China-related revenue concerns and potential regulatory/supply-chain issues. NVDA also faces upcoming earnings on 2026-05-20, which can increase uncertainty near term.
No usable latest-quarter financial snapshot was provided because the financial snapshot returned an error. From analyst expectations, the market is looking for roughly $81B in April-quarter revenue and about $90B-$91B for the July quarter, which implies very strong growth. This suggests the latest quarter season is QAPR 2026, with expectations still pointing to robust year-over-year expansion driven by AI infrastructure demand.
Analyst sentiment is very bullish and trending higher. Price targets were raised by UBS to $275, RBC kept $250, Cantor to $350, BofA to $320, Susquehanna to $275, Wells Fargo to $315, Raymond James to $323, and Argus stayed Buy at $220. The pros broadly see strong AI demand, supply tightness, and expanding long-term revenue potential. The main con view is valuation pressure, China risk, and skepticism around margin sustainability. Overall Wall Street is clearly positive, but the stock is already well-followed and expectations are high.
